Eleven years of qualification
Audited Supplier
In This Store
Established in 1995, Shenzhen Bona Pharma Technology Co., Ltd. focus on Drug delivery systems and Primary packages innovation and manufacturing. Customers in 73 countries likes Europe, the US, Australia, Japan and the Middle East has valued our products, including Merck, Novartis, Wyeth, Johnsons & Johnsons and Fisher Scientific.
Main products including: Nasal/Oral/Ear dosing spray pumps; Tablet bottles made of PP, PE and PET; Eye drop bottles; Vaginal and Enema Douches and Vaginal applicators;
Certifications:
--ISO15378:2017 certified manufacturer of primary packagings.
--ISO14001
--ISO9001
--ISO45001
--DMF# for Metered dose spray pump and Oral solid HDPE containers.
--Class 100,000 and 10,000 clean room. (ISO7 & 8 clean room, Class D and Class C clean room)
Year of Establishment: 1995
Total Assets(USD): More than 99,999,999
Total Number of Staff: 500-1000
Main Competitive Advantages: Brand Name,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Reputation,Quality Service
Other Competitive Advantages: 1. High-Tech Manufacturer Certification; 2. "BONA" Brand Certification; 3. Hygienic Manufacturing Enterprise; 4. Cleaner of Certification; 5. ISO 15378:2017 Certification; 6. ISO14001:2015 certification. 7. ISO45001:2018 certification. 7. US DMF# for HDPE container for oral solid medicines. 8. US DMF# for Nasal and Oral spray pump and bottles.
Patents and Copyrights: 1. Patent Certificate for Medicine Dispencer; 2. Patent Certificate for Gel Medicine Dispencer; 3. Patent Certificate for Talet Medicine Dispencer; 4. Patent Certificate for Liquid Medicine Spray Pump; 5. Patent Certificate for Spray Pump; 6. Patent Certificate for Preservative free pump. 7. Patent certificate for Child resistant nasal spray bottles. 6. Patent Certificate for Preservative free eye drops.
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us：
Pharma Sources Insight APRIL 2023
